These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9014291)

  • 1. Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe.
    Masson E; Cliquet F; Aubert M; Barrat J; Aubert A; Artois M; Schumacher CL
    Vaccine; 1996 Nov; 14(16):1506-10. PubMed ID: 9014291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species.
    Brochier B; Blancou J; Thomas I; Languet B; Artois M; Kieny MP; Lecocq JP; Costy F; Desmettre P; Chappuis G
    J Wildl Dis; 1989 Oct; 25(4):540-7. PubMed ID: 2681844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination.
    Cliquet F; Robardet E; Picard Meyer E
    Antiviral Res; 2013 Oct; 100(1):84-9. PubMed ID: 23899697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety evaluation of the SAG2 rabies virus mutant in Tunisian dogs and several non-target species.
    Hammami S; Schumacher CL; Cliquet F; Barrat J; Tlatli A; Ben Osman R; Aouina T; Aubert A; Aubert M
    Vet Res; 1999; 30(4):353-62. PubMed ID: 10478416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species.
    Vos A; Neubert A; Aylan O; Schuster P; Pommerening E; Müller T; Chivatsi DC
    Epidemiol Infect; 1999 Aug; 123(1):165-75. PubMed ID: 10487653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
    Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
    Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterisation of the rabies virus vaccine strains used for oral immunization of foxes in Poland to estimate the effectiveness of vaccination.
    Orłowska A; Żmudziński JF
    Arch Virol; 2015 Feb; 160(2):509-15. PubMed ID: 25408374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of SAG1 oral vaccine for the long-term protection of red foxes (Vulpes vulpes) against rabies.
    Artois M; Cliquet F; Barrat J; Schumacher CL
    Vet Rec; 1997 Jan; 140(3):57-9. PubMed ID: 9023904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELISA test for rabies antibody titration in orally vaccinated foxes sampled in the fields.
    Cliquet F; Sagné L; Schereffer JL; Aubert MF
    Vaccine; 2000 Aug; 18(28):3272-9. PubMed ID: 10869772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review.
    Mähl P; Cliquet F; Guiot AL; Niin E; Fournials E; Saint-Jean N; Aubert M; Rupprecht CE; Gueguen S
    Vet Res; 2014 Aug; 45(1):77. PubMed ID: 25106552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a vaccine bait containing ERA strain of attenuated rabies virus.
    Lawson KF; Black JG; Charlton KM; Johnston DH; Rhodes AJ
    Can J Vet Res; 1987 Oct; 51(4):460-4. PubMed ID: 3330965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2.
    Müller T; Selhorst T; Burow J; Schameitat A; Vos A
    Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vaccination of captive arctic foxes with lyophilized SAG2 rabies vaccine.
    Follmann EH; Ritter DG; Donald WH
    J Wildl Dis; 2004 Apr; 40(2):328-34. PubMed ID: 15362836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cell-mediated immune responses of foxes (Vulpes vulpes) after experimental primary and secondary oral vaccination using SAG2 and V-RG vaccines.
    Lambot M; Blasco E; Barrat J; Cliquet F; Brochier B; Renders C; Krafft N; Bailly J; Munier M; Aubert MF; Pastoret PP
    Vaccine; 2001 Feb; 19(13-14):1827-35. PubMed ID: 11166908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of arctic foxes (Alopex lagopus) with oral rabies vaccine.
    Follmann EH; Ritter DG; Baer GM
    J Wildl Dis; 1988 Jul; 24(3):477-83. PubMed ID: 3045347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Annual testing of immunity in foxes after oral rabies immunization].
    Vrzal V; Matouch O
    Vet Med (Praha); 1996 Apr; 41(4):107-11. PubMed ID: 8693662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs.
    Bankovskiy D; Safonov G; Kurilchuk Y
    Dev Biol (Basel); 2008; 131():461-6. PubMed ID: 18634508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine.
    Black JG; Lawson KF
    Can J Comp Med; 1980 Apr; 44(2):169-76. PubMed ID: 7407689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of foxes with avirulent rabies virus mutants.
    Le Blois H; Tuffereau C; Blancou J; Artois M; Aubert A; Flamand A
    Vet Microbiol; 1990 Jun; 23(1-4):259-66. PubMed ID: 2402873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine.
    Rupprecht CE; Dietzschold B; Cox JH; Schneider LG
    J Wildl Dis; 1989 Oct; 25(4):548-54. PubMed ID: 2810555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.